Search

Your search keyword '"QIAGEN N.V. -- Product introduction"' showing total 72 results
Start Over Descriptor "QIAGEN N.V. -- Product introduction"
72 results on '"QIAGEN N.V. -- Product introduction"'

2. Qiagen introduces QIAcuityDx digital PCR system for clinical testing in oncology

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Pharmaceuticals and cosmetics industries
Abstract

Qiagen N.V., a Netherlands-based holding company, is the leading global provider of sample to insight solutions, announced the launch of the QIAcuityDx Digital PCR System, a pivotal addition to its [...]

Published
2024

3. QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data

Subjects
QIAGEN N.V. -- Product introduction, Natural language interfaces -- Product introduction, Computational linguistics -- Product introduction, Language processing -- Product introduction, Business, Business, international
Abstract

* Ingenuity Pathway Analysis Interpret extends analysis capabilities of human-curated knowledge base with AI technology * AI-extension highlights key biological elements at work and provides summarized results and interpretations in [...]

Published
2024

5. QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Urinary tract infections, Medical research, Medicine, Experimental, Communicable diseases, Disease transmission, Telecommunications industry
Abstract

(GlobeNewswire) - QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of 35 new wet-lab tested digital PCR Microbial DNA Detection Assays for its digital PCR (dPCR) platform [...]

Published
2024

6. QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Banking, finance and accounting industries, Business
Abstract

Germantown, Maryland, and Venlo, the Netherlands, June 03, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAstat-Dx Gastrointestinal Panel 2 in [...]

Published
2024

8. QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolation

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, RNA, Petroleum, energy and mining industries
Abstract

(GlobeNewswire) - QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its sample technologies portfolio with the introduction of two new products aimed at supporting researchers in [...]

Published
2023

9. QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolation

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, RNA, Banking, finance and accounting industries, Business
Abstract

Venlo, the Netherlands, Nov. 15, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its sample technologies portfolio with the introduction of two [...]

Published
2023

10. QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customers

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Food -- Safety and security measures, RNA, Banking, finance and accounting industries, Business
Abstract

Venlo, the Netherlands, Nov. 09, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of three new kits for use on its QIAcuity systems [...]

Published
2023

11. QIAGEN launches complete Sample to Insight workflow for microbiome research

Subjects
QIAGEN N.V. -- Product introduction, Workflow software, Telecommunications industry
Abstract

(GlobeNewswire) - QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the Microbiome WGS SeqSets, a comprehensive Sample to Insight workflow designed to provide an easy-to-use solution [...]

Published
2023

12. QIAGEN launches complete Sample to Insight workflow for microbiome research

Subjects
QIAGEN N.V. -- Product introduction, Workflow software, Banking, finance and accounting industries, Business
Abstract

Venlo, the Netherlands, Nov. 06, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the Microbiome WGS SeqSets, a comprehensive Sample to Insight [...]

Published
2023

13. Qiagen adds new biopharma products to QIAcuity digital PCR portfolio and launches expert custom assay design service

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Integrated software -- Product introduction, Business application suite, Pharmaceuticals and cosmetics industries
Abstract

Qiagen announced a series of enhancements for its QIAcuity series of digital PCR (dPCR) instruments designed to drive greater use among customers, particularly those involved in the biopharma industry. New [...]

Published
2022

15. QIAGEN launches QuantiFERON-EBV RUO assay, facilitating research of cell-mediated immune response to Epstein-Barr virus

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Medical research, Medicine, Experimental, Immune response, Immunotherapy, Epidemiology, Epstein-Barr virus, Organ transplant recipients, Banking, finance and accounting industries, Business
Abstract

Venlo, the Netherlands, Oct. 04, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its QuantiFERON-EBV RUO (Research Use Only) assay. Epstein-Barr virus [...]

Published
2023

16. QIAGEN exceeds outlook for Q1 2023 with 12% CER sales growth in non-COVID product portfolio

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Banking, finance and accounting industries, Business
Abstract

Venlo, the Netherlands, May 03, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced results for the first quarter of 2023. Net sales for Q1 2023 declined [...]

Published
2023

19. QIAGEN Introduces Portable Digital SARS-CoV-2 Antigen Test

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Arts and entertainment industries, QIAreach SARS-CoV-2 Antigen Test (Medical test kit) -- Product introduction
Abstract

QIAGEN has started commercialization of a portable digital test in the United States that can be used by laboratories to detect SARS-CoV-2 antigens in people with active infections in 2-15 [...]

Published
2020

20. QIAGEN adds new biopharma products to QIAcuity digital PCR portfolio and launches Expert Custom Assay Design Service

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Integrated software -- Product introduction, Business application suite, General interest, News, opinion and commentary
Abstract

HILDEN: QIAGEN N.V. has issued the following news release: QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today a series of enhancements for its QIAcuity series of digital PCR (dPCR) [...]

Published
2022

22. QIAGEN's Eco-Friendlier Products Earn Prestigious ACT Label

Subjects
QIAGEN N.V. -- Product introduction, Sustainable living, Business, Business, international
Abstract

* QIAwave products showed 35% lower environmental impact * First in industry to receive ACT label for sample preparation kits * QIAGEN and My Green Lab to collaborate on laboratory [...]

Published
2022

24. Global Multiplex Assay Market Size, Share & Industry Trends Analysis Report By Product, By Type, By End user, By Application, By Regional Outlook and Forecast, 2021 - 2027

Subjects
QIAGEN N.V. -- Product introduction, Thermo Fisher Scientific Inc. -- Product introduction, Becton, Dickinson and Co. -- Product introduction, Bio-Rad Laboratories Inc. -- Product introduction, Luminex Corp. -- Product introduction, Illumina Inc. -- Product introduction, Biological products industry -- Product introduction -- Industry forecasts, Scientific equipment and supplies industry -- Industry forecasts -- Product introduction, Medical test kit industry -- Industry forecasts -- Product introduction, Biotechnology industry -- Product introduction -- Industry forecasts, Enzyme-linked immunosorbent assay, Medical equipment and supplies industry -- Industry forecasts -- Product introduction, Proteins, Instrument industry -- Product introduction -- Industry forecasts, General interest, News, opinion and commentary
Abstract

New York: ReportLinker has issued the following news release: Reportlinker.com announces the release of the report 'Global Multiplex Assay Market Size, Share & Industry Trends Analysis Report By Product, By [...]

Published
2022

25. Global Multiplex Assay Market Size, Share & Industry Trends Analysis Report By Product, By Type, By End user, By Application, By Regional Outlook and Forecast, 2021 - 2027

Subjects
QIAGEN N.V. -- Product introduction, Thermo Fisher Scientific Inc. -- Product introduction, Becton, Dickinson and Co. -- Product introduction, Bio-Rad Laboratories Inc. -- Product introduction, Luminex Corp. -- Product introduction, Illumina Inc. -- Product introduction, Biological products industry -- Product introduction -- Industry forecasts, Scientific equipment and supplies industry -- Industry forecasts -- Product introduction, Medical test kit industry -- Industry forecasts -- Product introduction, Biotechnology industry -- Product introduction -- Industry forecasts, Enzyme-linked immunosorbent assay, Medical equipment and supplies industry -- Industry forecasts -- Product introduction, Proteins, Instrument industry -- Product introduction -- Industry forecasts, Banking, finance and accounting industries, Business
Abstract

New York, April 04, Apr 04, 2022 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Global Multiplex Assay Market Size, Share & Industry Trends Analysis Report [...]

Published
2022

27. QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Biological apparatus and supplies -- Product introduction, Business, Business, international, QIAwave Nucleic Acid Extraction Kits (Medical instrument) -- Product introduction
Abstract

* New extraction kits reduce use of plastics by up to 63% and cardboard by up to 42% compared to QIAGEN standard kits * Three offerings are first of a [...]

Published
2022

28. QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput version

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Business, Business, international
Abstract

* New tests for QIAstat-Dx syndromic solution to distinguish between gastrointestinal pathogens (U.S. submission) and between meningitis and encephalitis infections (CE-IVD registration) * Higher-capacity QIAstat-Dx Rise platform set for CE-IVD [...]

Published
2022

30. QIAGEN launches the Workflow Configurator to help life science researchers simplify and optimize their laboratory experiments

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Workflow software, Business, Business, international
Abstract

* Cloud application marks another milestone for QIAGEN by adding guidance for customers along the entire product portfolio * Application covers seamless portfolio transition from 'wet lab' benchtop products through [...]

Published
2021

32. QIAGEN Launches QIAsphere Cloud-Based Connectivity Solution to Enhance QIAstat-Dx Capabilities in Digital Diagnostics

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Cloud computing, Business, Business, international
Abstract

* Major step towards bringing customer service to critical and syndromic testing * QIAsphere mobile App enables real-time and remote test monitoring from anywhere, and will be available for additional [...]

Published
2021

33. Health Highlights: Sept. 9, 2020; Pandemic Threatens Gains in Reducing Preventable Childhood Deaths Clinical Trial of AstraZeneca Coronavirus Vaccine Paused After Illness New COVID-19 Test Provides Results in 15 Minutes

Subjects
QIAGEN N.V. -- Product introduction, AstraZeneca PLC -- Product development, Clinical trials, Vaccines -- Testing -- Complications and side effects, Pediatric research, Epidemics -- Statistics -- United Kingdom -- Netherlands, Child death -- Health aspects, Coronavirus test kits -- Product introduction, Pharmaceutical industry -- Product development, COVID-19 -- Complications and side effects -- Care and treatment -- Statistics, Biological products industry -- Product introduction, Health
Abstract

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Pandemic Threatens Gains in Reducing Preventable Childhood Deaths The coronavirus pandemic threatens decades [...]

Published
2020

34. Global Tumor Genomics Market: Focus on Products, Techniques, Applications, End User, Cancer Type, 14 Countries Data, Industry Insights and Competitive Landscape - Analysis and Forecast, 2019-2028

Subjects
QIAGEN N.V. -- Product introduction, Thermo Fisher Scientific Inc. -- Product introduction, Illumina Inc. -- Product introduction, Cancer -- Methods -- Reports, Medium term notes, Drug discovery, Polymerase chain reaction, Dacomitinib, Immunohistochemistry, End users, Spectroscopy, Backup software, Tumors, Ambulatory care facilities, Banking, finance and accounting industries, Business
Abstract

New York, June 04, Jun 04, 2020 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Global Tumor Genomics Market: Focus on Products, Techniques, Applications, End User, [...]

Published
2020

35. Advances in polymerase chain reaction; New PCR technologies aid in product development

Author

Dutton, Gail

Subjects
QIAGEN N.V. -- Product introduction, PNA Diagnostics A/S -- Product information, Biological products industry -- Product information, Biotechnology industry, Business
Abstract

Such companies as PNA Diagnostics A/S and Qigan N.V. are developing means to facilitate the testing of polymerase chain reaction (PCR). PNA uses the properties of peptide nucleic acid (PNA) to improve the extraction of nucleic acids from the patient sample. An official with the company stated that PNA Diagnostics hopes to remove non-nucleic acid substances from the patient sample that can stifle PCR reaction. Qiagen N.V. has introduced a new enzyme called Hot Star Taq, which increases the specificity of every cycle of the assay process save the first, the extraction of nucleic acids from the patient.

Published
1998

36. QIAGEN Launches First FDA-Approved Companion Diagnostic Using FGFR Alterations to Help Guide the Treatment of Metastatic Urothelial Cancer

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Cancer -- Drug therapy, Fibroblast growth factors, Cancer metastasis -- Drug therapy, Cancer patients, Biotechnology, Tumors, Novels, Business, Business, international
Abstract

Novel therascreen([R] ) FGFR RGQ RT-PCR Kit will aid in identifying patients eligible for treatment with BALVERSA ([TM] ) (erdafitinib), developed by Janssen GERMANTOWN, Md. & HILDEN, Germany -- QIAGEN [...]

Published
2019

38. QIAGEN Launches Novel RNA-Seq Library Preparation Solutions for Next-Generation Sequencing

Subjects
QIAGEN N.V. -- Product introduction, Libraries, RNA sequencing, Biological products industry -- Product introduction, RNA, General interest, News, opinion and commentary
Abstract

HILDEN: QIAGEN N.V. has issued the following press release: QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of a breakthrough technology enabling faster, simpler library preparation [...]

Published
2018

39. QIAGEN Launches Novel RNA-Seq Library Preparation Solutions for Next-Generation Sequencing

Subjects
QIAGEN N.V. -- Product introduction, Libraries, RNA sequencing, Biological products industry -- Product introduction, RNA, Business, Business, international, American Society of Human Genetics
Abstract

Studies on new QIAGEN solutions for NGS are presented at ASHG as QIAseq portfolio and user base expands significantly HILDEN, Germany & GERMANTOWN, Md. -- QIAGEN N.V. (NYSE: QGEN; Frankfurt [...]

Published
2018

40. Germany : QIAGEN launches predictive therascreen PITX2 test in Europe to guide treatment in high-risk breast cancer

Subjects
QIAGEN N.V. -- Product introduction, Epigenetic inheritance, Medical tests, Anthracyclines -- Product introduction, Methylation, Recurrence (Disease), Chemotherapy, Breast cancer, Biological products industry -- Product introduction, Business, international
Abstract

QIAGEN N.V. announced the European launch of its novel therascreen PITX2 RGQ PCR Kit, the first clinically validated DNA methylation assay that helps predict the response of certain high-risk breast [...]

Published
2018

41. QIAGEN launches predictive therascreen PITX2 test in Europe to guide treatment in high-risk breast cancer

Subjects
QIAGEN N.V. -- Product introduction, Epigenetic inheritance, Medical tests, Anthracyclines -- Product introduction, Methylation, Chemotherapy, Breast cancer, Biological products industry -- Product introduction, General interest, News, opinion and commentary
Abstract

Hilden: Qiagen N.V. has issued the following press release: QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of its novel therascreen PITX2 RGQ PCR Kit, [...]

Published
2018

42. QIAGEN launches predictive therascreen PITX2 test in Europe to guide treatment in high-risk breast cancer

Subjects
QIAGEN N.V. -- Product introduction, Epigenetic inheritance, Medical tests, Anthracyclines -- Product introduction, Methylation, Chemotherapy, Breast cancer, Biological products industry -- Product introduction, General interest, News, opinion and commentary
Abstract

Hilden: Qiagen N.V. has issued the following press release: QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of its novel therascreen PITX2 RGQ PCR Kit, [...]

Published
2018

43. QIAGEN launches predictive therascreen PITX2 test in Europe to guide treatment in high-risk breast cancer

Subjects
QIAGEN N.V. -- Product introduction, Epigenetic inheritance, Medical tests, Anthracyclines -- Product introduction, Methylation, Chemotherapy, Breast cancer, Biological products industry -- Product introduction, General interest, News, opinion and commentary
Abstract

Hilden: Qiagen N.V. has issued the following press release: QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of its novel therascreen PITX2 RGQ PCR Kit, [...]

Published
2018

44. QIAGEN launches predictive therascreen PITX2 test in Europe to guide treatment in high-risk breast cancer

Subjects
QIAGEN N.V. -- Product introduction, Epigenetic inheritance, Medical tests, Anthracyclines -- Product introduction, Methylation, Chemotherapy, Breast cancer, Biological products industry -- Product introduction, General interest, News, opinion and commentary
Abstract

Hilden: Qiagen N.V. has issued the following press release: QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of its novel therascreen PITX2 RGQ PCR Kit, [...]

Published
2018

45. Qiagen, LabCorp Launch Collaboration to Provide Day-One Access for Patients to Innovative Companion Diagnostics at the Time of Drug Approvals

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, Drugs -- Product introduction, Cancer patients, Backup software, Printing inks, Chemistry
Abstract

M2 PHARMA-April 8, 2019-Qiagen, LabCorp Launch Collaboration to Provide Day-One Access for Patients to Innovative Companion Diagnostics at the Time of Drug Approvals (C)2019 M2 COMMUNICATIONS - Dutch diagnostics developer [...]

Published
2019

46. QIAGEN and ICMP Launch Next-Generation DNA Testing Solutions for Identifying Missing Persons

Subjects
QIAGEN N.V. -- Product introduction, DNA identification, Workflow software -- Product introduction, DNA, Missing persons, Biological products industry -- Product introduction, Workflow software, Business, News, opinion and commentary
Abstract

THE HAGUE, the Netherlands, October 24, 2017 /PRNewswire/ -- The International Commission on Missing Persons (ICMP) today announced the launch of a cutting-edge next-generation sequencing (NGS) workflow created in collaboration [...]

Published
2017

47. Qiagen Launches Novel RNA-Seq Library Preparation Solutions for Next-Generation Sequencing

Subjects
QIAGEN N.V. -- Product introduction, Libraries, RNA sequencing, Biological products industry -- Product introduction, RNA, Chemistry
Abstract

M2 PHARMA-October 12, 2018-Qiagen Launches Novel RNA-Seq Library Preparation Solutions for Next-Generation Sequencing (C)2018 M2 COMMUNICATIONS - German life science company Qiagen N.V. (NYSE: QGEN) has launched technology offering faster, [...]

Published
2018

48. QIAGEN unveils unique Sample to Insight solutions for liquid biopsies and hereditary diseases

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, General interest, News, opinion and commentary
Abstract

Hilden: Qiagen N.V. has issued the following press release: QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAseq(r) cfDNA All-in-One Kit, combining cell-free DNA [...]

Published
2016

49. QIAGEN unveils unique Sample to Insight solutions for liquid biopsies and hereditary diseases

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, General interest, News, opinion and commentary
Abstract

Hilden: Qiagen N.V. has issued the following press release: QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAseq(r) cfDNA All-in-One Kit, combining cell-free DNA [...]

Published
2016

50. QIAGEN unveils unique Sample to Insight solutions for liquid biopsies and hereditary diseases

Subjects
QIAGEN N.V. -- Product introduction, Biological products industry -- Product introduction, General interest, News, opinion and commentary
Abstract

Hilden: Qiagen N.V. has issued the following press release: QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAseq(r) cfDNA All-in-One Kit, combining cell-free DNA [...]

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results